Filter results
You can narrow down the results using the filters
Content type
Gene Technology Ministers’ Meeting – Communique – 13 April 2023
This document is a summary of the Gene Technology Ministers’ Meeting (GTMM) held on Thursday 13 April 2023.
1:13Overview of the scheme in Australia
Learn about Australia's National Gene Technology Scheme and how gene technology and genetically modified organisms are regulated in Australia.
2017 review – Consultation regulation impact statement – Explanatory paper
This paper explains the operational implementation details needed for both priority recommendations of the 2017 review of the National Gene Technology Scheme.
2017 review – Consultation regulation impact statement and explanatory paper submissions
The National Gene Technology Scheme received these submissions for a third review consultation on a ‘Regulation impact statement’ and ‘Explanatory paper’. It excludes those made on a confidential basis. Submissions to this consultation closed on 17 March 2021.
2017 review – Regulation impact statement and explanatory paper – Submission – Acceligen
Acceligen sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – Animal Medicines Australia
Animal Medicines Australia sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – ANU Recombinant DNA Monitoring Committee
The Australian National University's Recombinant DNA Monitoring Committee sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – APVMA
The Australian Pesticides and Veterinary Medicines Authority sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – AusBiotech
AusBiotech sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – AAS and AATSE
The Australian Academy of Science and the Australian Academy of Technology and Engineering sent this joint submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – Australian Seed Federation
The Australian Seed Federation sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – BASF
BASF sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – CropLife Australia
CropLife Australia sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – Gene Ethics
Gene Ethics sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – QUT
Queensland University of Technology sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – RPA Hospital's IBC
The Royal Prince Alfred Hospital's Institutional Biosafety Committee sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – Rare Disease Industry Working Group
The Rare Disease Industry Working Group sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Regulation impact statement and explanatory paper – Submission – Department of Primary Industries and Regional Development
Western Australia's Department of Primary Industries and Regional Development sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.
2017 review – Consultation regulation impact statement – Modernising and future-proofing the National Gene Technology Scheme
This consultation regulation impact statement presents 2 options for implementing key recommendations of the 2017 review through a proposed regulatory framework.
Gene Technology Ministers’ Meeting – Communique – July 2021
This document is a summary of the Gene Technology Ministers’ Meeting (GTMM) held on Tuesday 20 July 2021.
2017 review – Decision regulation impact statement
This decision regulation impact statement outlines 3 policy options to implement the recommendations of the third review of the National Gene Technology Scheme.
2017 review – Updated action plan 2020–2023
This updated action plan for implementing recommendations from the 2017 of the National Gene Technology Scheme takes into account changes arising from the 2020 review of COAG councils and ministerial forms.
2017 review – Consultation regulation impact statement and explanatory paper – Frequently asked questions
This fact sheet contains a selection of questions and answers that address key issues raised during information sessions. The information sessions covered the consultation regulation impact statement and explanatory paper – part of the 2017 review of the National Gene Technology Scheme.
Legislative and Governance Forum on Gene Technology – Communique – 11 December 2020
This communique outlines the outcomes from the meeting held on 11 December 2020. The forum is now known as the Gene Technology Ministers’ Meeting.
Gene Technology Ministers’ Meeting – Communiques
This collection contains communiques from the Gene Technology Ministers’ Meeting, previously named the Legislative Governance Forum on Gene Technology.